Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

v3.24.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2021 $ 1 $ 47,803,770 $ (41,499,522) $ 6,304,249
Beginning balance, shares at Dec. 31, 2021 77,260      
Issuance of common stock for public offering, net of issuance costs of $1,910,816 18,089,184 18,089,184
Beginning balance, shares 29,630      
Issuance of common stock for cashless exercise of warrants
Beginning balance, shares 375      
Issuance of common stock for exercise of stock options and restricted shares 40,000 40,000
Beginning balance, shares 1,068      
Reclassification of derivative liabilities to equity       0
Stock-based compensation 3,259,009 3,259,009
Beginning balance, shares 243      
Forfeiture of performance shares
Beginning balance, shares (14)      
Issuance of note warrants and underwriter warrants, net of issuance costs of $1,003,513 7,177,976 7,177,976
Net loss (34,235,405) (34,235,405)
Ending balance, value at Dec. 31, 2022 $ 1 76,369,939 (75,734,927) 635,013
Beginning balance, shares at Dec. 31, 2022 108,562      
Issuance of common stock for public offering, net of issuance costs of $1,910,816 4,570,085 4,570,085
Beginning balance, shares 32,889      
Issuance of common stock for exercise of stock options and vesting of restricted stock units 25,000 25,000
[custom:IssuanceOfCommonStockForExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares] 314      
Issuance of common stock units in public offering, net of issuance costs of $28,777 $ 1 255,504 255,505
Stock Issued During Period, Shares, Other 73,913      
Issuance of pre-funded warrant units, net of issuance costs of $342,071 3,037,121 3,037,121
Issuance of common stock for exercise of pre-funded warrants $ 8 8
[custom:IssuanceOfCommonStockForExerciseOfPrefundedWarrantsShares] 804,618      
Issuance of common stock for cashless exercise of warrants 680,978 680,978
Beginning balance, shares 9,156      
Proceeds received for reduction of warrant exercise price 346,500 346,500
Reclassification of derivative liabilities to equity 13,262,055 13,262,055
Stock-based compensation 2,627,925 2,627,925
Beginning balance, shares 618      
Net loss (45,071,211) (45,071,211)
Ending balance, value at Dec. 31, 2023 $ 10 $ 101,175,107 $ (120,806,138) $ (19,631,021)
Beginning balance, shares at Dec. 31, 2023 1,030,070